PD-L1-upregulated expression on cancer cells occurs via four primary mechanisms: (I) the DNA damage signaling pathway; (II) interferon gamma (IFN-γ) signaling; (III) the cGAS-STING pathway; and (IV) the epidermal growth factor receptor (EGFR) pathway. Here, IFNG is linked to cancer.